In a first-of-its-kind safety research study, University of Florida researchers have injected an anti-inflammatory compound into the eye of a person with a sight-robbing disease. The procedure was performed last month to test the safety and effectiveness of a synthetic peptide — a small protein fragment — in procedures involving the human eye.